Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Family Medicine
Clinical Trials: Neoplasms
A listing of clinical trials currently looking for volunteers to enroll in Neoplasms studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Bessemer : Birmingham Hematology and Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Birmingham : Birmingham Hematology and Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Birmingham : Urology Centers of Alabama, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Birmingham : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Birmingham : 1200.75.10013 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Birmingham : University Of Alabama at Birmingham
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Birmingham : University of Alabama at Birmingham
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Birmingham :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Birmingham :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Birmingham : University of Alabama at Birmingham
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Homewood :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Muscle Shoals : Investigational Site Number 840-002
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Alaska
Anchorage : Alaska Clinical Research Center, Llc
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Anchorage : Alaska Clinical Research Center, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Anchorage :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Arizona
Chandler : Ironwood Cancer and Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Chandler : New Horizons Women's Care, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Chandler : 1200.75.10051 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Flagstaff : Call for Information (Investigational Site 9109) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Goodyear : Weatern Regional Medical Center / Cancer Treatment Centers of America
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Phoenix :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Phoenix : Arizona OB/GYN Affiliates, PC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : Precision Trials
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : Barrow Neurological Institute, St. Joseph's Hospital and Medical Center
In Vivo Confocal Microscopy Tumor Atlas Study
Phoenix : Investigational Site Number 840007
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Phoenix :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Scottsdale : Investigational Site Number 840002
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Scottsdale : Pinnacle Oncology Hematology,
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
Scottsdale : Scottsdale Clinical Research Institute
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Scottsdale : Scottsdale Healthcare
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Scottsdale : AVEO Clinical Site
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Scottsdale : Scottsdale Healthcare, Site #134
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Scottsdale : Pinnacle Oncology Hematology, Oncology Research Associates, PLLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Scottsdale : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Scottsdale : Mayo Clinic
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Scottsdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
Scottsdale : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Scottsdale :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
Scottsdale : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Scottsdale : Investigational Site Number 840003
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Scottsdale :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Scottsdale : TGEN Clinical Research Services at Scottsdale Healthcare
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Scottsdale : Mayo Clinic Arizona
Dose-escalation Study of Oral CX-4945
Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
Scottsdale : Mayo Clinic in Arizona
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Scottsdale : Oncology Research Associates
Phase 1 Study of ONX 0912 Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors
Scottsdale : Mayo Clinic Arizona
Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Scottsdale :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Scottsdale : Virginia G Piper Cancer Center
Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies
Scottsdale : Oncology Research Associates
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
Scottsdale : TGen Clinical Research Service at Scottsdale Healthcare
Safety Study of PLX108-01 in Patients With Solid Tumors
Scottsdale : Site Reference ID/Investigator# 64046
Study of ABT-700 in Subjects With Advanced Solid Tumors
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Scottsdale : TGen Clinical Research Services
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Scottsdale :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Scottsdale : Pinnacle Oncology Hematology
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Scottsdale : Investigational Site Number 840008
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Sedona : Call for Information (Investigational Site 0006) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Tucson : Arizona Cancer Center
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Tucson : Call for Information (Investigational Site 0013) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Tucson : Arizona Oncology Associates, PC - HOPE
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tucson : Urological Associates of Southern Arizona, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tucson : Arizona Institute of Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tucson : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Tucson : Urology Associates of Southern Arizona
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Tucson :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Tucson : Visions Clinical Research - Tucson
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Tucson : The University of Arizona Cancer Center - North Campus
Clinical Study of WT2725 in Patients With Advanced Solid Malignancies
Tucson : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Tucson :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Tucson : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Tucson : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Tucson : Southern Arizona VA Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Tuscon :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Arkansas
Fayetteville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Fayetteville : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Fayetteville : Highlands Oncology Group Dept of Highlands Oncology Grp
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Jonesboro : 1200.75.10034 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Little Rock : Little Rock Hematology Oncology: A Division of CARTI
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Little Rock : Call for Information (Investigational Site 0385)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Little Rock : 1200.43.00101 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Rogers : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Rogers : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
California
Alhambra : 1200.75.10113 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Alhambra : 1200.67.10103 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Anaheim : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bakersfield : Call for Information (Investigational Site 0326)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bakersfield : 1200.67.10106 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
View More »
Bakersfield : Comprehensive Blood and Cancer Center
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Berkeley : Alta Bates Summit Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Berkeley : Call for Information (Investigational Site 0015)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Burbank : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Burbank : Call for Information (Investigational Site 0324)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Campbell : Call for Information (Investigational Site 0312)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Chula Vista : South County Hematology/Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Colton :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Corona : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Duarte : City of Hope National Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Duarte : Site Reference ID/Investigator# 23283
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Duarte : Site Reference ID/Investigator# 27743
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Duarte : City of Hope Medical Center
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Encino : Urology Specialists of Southern California
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fair Oaks : Call for Information (Investigational Site 0380)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Fountain Valley : Robert A. Moss, M.D., F.A.C.P., Inc
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fountain Valley : 1200.75.10010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fullerton : 1200.75.10112 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fullerton : 1200.67.10105 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Gilroy :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Glendale : Pacific Shores Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Glendora : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Greenbrae : Call for Information (Investigational Site 0047) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Greenbrae : Marin Cancer Care
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Highland : Beaver Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Highland : Call for Information (Investigational Site 0430)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Highland :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Hollywood : 1200.67.10107 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Huntington Beach : Pacific Shores Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
La Jolla : UCSD Medical Center - La Jolla
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
La Jolla : UCSD Moores Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
La Jolla : Moores UCSD Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
La Jolla : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
La Jolla : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
La Jolla : Call for Information (Investigational Site 0251)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
La Jolla : Moores University of California San Diego Cancer Center
Safety and PK Study of RRx-001 in Cancer Subjects
La Jolla : University of California, San Diego
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
La Jolla : Investigational Site Number 840004
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
La Mesa : Cancer Center Oncology Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
La Mesa :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa : Grossmont Center for Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
La Verne : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Loma Linda : Investigational Site Number 840013
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Long Beach : Pacific Shores Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Long Beach : 1200.75.10052 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Long Beach : 1200.75.10104 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Los Alamitos : Pacific Shores Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Los Angeles : UCLA/ University of California Los Angeles Div. of Hematology/Oncology
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Los Angeles : Investigational Site Number 840004
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Los Angeles : UCLA/ University of California Los Angeles UCLA LeConte Location
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Los Angeles : Research Site
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Los Angeles : Cedars-Sinai Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : University of California Los Angeles
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : USC Norris Comprehensive Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Los Angeles : Cedars-Sinai Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Los Angeles : UCLA Institute of Urologic Oncology, UCLA Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Los Angeles : USC / Norris Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Los Angeles : Tower Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Los Angeles : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Los Angeles : Samuel Oschin Comprehensive Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
Los Angeles :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Los Angeles : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Los Angeles : UCLA/ University of California Los Angeles Div. of Hematology/Oncology
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Los Angeles : 1200.89.10001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Los Angeles : Cedars-Sinai Medical Center
Combination Trial MSC1936369B With Temsirolimus
Los Angeles : Pfizer Investigational Site
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
Los Angeles :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Los Angeles : 1200.75.10004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Los Angeles : 1200.67.10001 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Los Angeles : 1200.131.00178 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Los Angeles : Investigational Site Number 840008
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Los Angeles : University of Southern California, Norris Comprehensive Cancer Center
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
Los Angeles : UCLA
Safety Study of PLX108-01 in Patients With Solid Tumors
Los Angeles :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Los Angeles :
Sorafenib Long Term Extension Program (STEP)
Los Angeles :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Los Angeles :
Study of GDC-0973/XL518 in Patients With Solid Tumors
Los Angeles : Cedars Sinai Medical Center Cedars Sinai 4
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Los Angeles : Cedars Sinai Medical Center The Pituitary Center (3)
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Los Angeles : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Los Angeles : Samuel Oschin Comprehensive Cancer Institute
Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors
Los Angeles : Investigational Site Number 840005
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Marina del Rey : Prostate Oncology Speciality Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marina del Rey :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Mission Hills : Call for Information (Investigational Site 0121)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Mission Hills : Call for Information (Investigational Site 0252)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Montebello : 1200.75.10042 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Murrieta : Tri Valley Urology Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Newport Beach : Gynecologic Oncology Associates
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
Newport Beach : Investigational Site Number 1526
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Northridge : 1200.75.10101 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Oceanside : North County Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : Hematology-Oncology Medical Group of Orange County, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : Medical Oncology Care Associates (MOCA)
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : The Center for Cancer Prevention and Treatment, St. Joseph Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange : Department of Obstetrics and Gynecology, University of California, Irvine
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Orange : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Orange : University of California - Irvine
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Orange :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Orange : University of California Irvine Medical Center
TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Orange : University of California Irvine
Tracking Renal Tumors After Cryoablation Evaluation
Oxnard : PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Palo Alto : Investigational Site Number 840011
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Pasadena : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pasadena : Huntington Memorial Hospital/Hill Breast Center
Earlier Breast Cancer Detection Using Automated Whole Breast Ultrasound With Mammography, Including Cost Comparisons
Pasadena : South Pasadena Cancer Center
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Pleasant Hill : Call for Information (Investigational Site 0381)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Pleasant Hill : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Pleasant Hill : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Pleasanton : Valley Medical Oncology Consultants
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pleasanton : Valley Medical Oncology Consultants
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Pomona : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rancho Cucamonga : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rancho Mirage : Call for Information (Investigational Site 0350)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Rancho Mirage :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Redondo Beach : 1200.75.10109 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Roseville : Sutter Roseville Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Roseville : Call for Information (Investigational Site 0236)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Sacramento : Radiological Associates of Sacramento
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Sacramento : Sutter Cancer Center / Sacramento Center for Hematology and Medical Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sacramento : Sutter Memorial Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sacramento : University of California - Davis
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Sacramento : University of California Davis Cancer Center
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Sacramento : University of California at Davis
Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer
Salinas : Investigational Site Number 840011
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
San Bernardino : San Bernardino Urological Associates
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
San Diego : University of California, San Diego: Moores Cancer Center, Site #099
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
San Diego : San Diego Clinical Trials
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
San Diego : Genesis Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Diego : Sharp Rees-Stealy
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Diego : Medical Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Diego : Sharp Clinical Oncology Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Diego : UCSD Medical Center - Hillcrest
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Diego : Genesis Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
San Diego : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
San Diego : Sharp Memorial Hospital
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
San Diego :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
San Diego : UCSD Moores Cancer Research Institute
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
San Diego : San Diego Pacific Oncology & Hematology Assoc Inc.
Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
San Diego :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
San Francisco : UCSF-Helen Diller Family Comprehensive Cancer Care Center
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
San Francisco : Call for Information (Investigational Site 0010) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
San Francisco : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
San Francisco : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
San Francisco : Call for Information (Investigational Site 0001)
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
San Francisco : UCSF
Bone Graft Materials Observational Registry
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
San Francisco : Investigational Site Number 840005
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
San Francisco : GSK Investigational Site
Dose-Escalation Study of GSK2126458
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
San Francisco :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
San Francisco : Research Site
Panitumumab Pediatric Study
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Phase I Tolerability, Efficacy, and Safety Study of Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression
San Francisco : Investigational Site Number 840003
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
San Francisco : Investigational Site Number 840004
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center
Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
San Francisco : Investigational Site Number 840014
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
San Francisco : Call for Information (Investigational Site 0001)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
San Marcos :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Santa Ana : Edward Alexson, MD, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Santa Barbara : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Santa Barbara : 1200.75.10103 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Barbara : 1200.75.10106 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Barbara : 1200.67.10108 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Santa Maria : 1200.75.10102 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Maria : 1200.67.10102 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Santa Monica : Call for Information (Investigational Site 0009)
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Santa Monica : UCLA Santa Monica Hematology-Oncology
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
Santa Monica : UCLA Hematology-Oncology Santa Monica
Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Santa Monica : Sarcoma Oncology Center
Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors
Santa Monica : University of California Los Angeles (UCLA)
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Santa Monica : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Santa Monica : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Santa Monica : Premiere Oncology
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Santa Monica : UCLA Hematology-Oncology
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Spring Valley : Call for Information (Investigational Site 0237)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Stanford : Stanford University Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stanford : Stanford Cancer Center - Stanford University
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Stanford : Call for Information (Investigational Site 0341)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Stanford : Stanford University School of Medicine
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Stanford : Stanford University School of Medicine
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Stanford : Stanford University Medical Center SC
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Stanford : Stanford University School of Medicine
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Stockton : Stockton Hematology Oncology Medical Group
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stockton : Call for Information (Investigational Site 0242)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Torrance :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Walnut Creek : Contra Costa Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
West Covina : Wilshire Oncology Medical Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
West Hollywood : James R. Berenson MD, Incorporated
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Whittier : 1200.75.10039 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Colorado
Aurora : University of Colorado Dept. of Anschutz Cancer (3)
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Aurora : University of Colorado Hospital
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
Aurora :
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Aurora : University of Colorado Hospital, Site #015
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Aurora : University of Colorado
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
View More »
Aurora : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Aurora :
A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors
Aurora : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Aurora : Call for Information (Investigational Site 0003)
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
Aurora : Call for Information (Investigational Site 0444)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Aurora : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Aurora : Children's Hospital Colorado
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Aurora :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Aurora : University of Colorado Denver
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Aurora :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Aurora : University of Colorado Denver
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Aurora : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Aurora :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Aurora : Call for Information (Investigational Site 0003)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Aurora : Pfizer Investigational Site
Study Of PI3K/mTOR Inhibitors In Combination With A MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Boulder : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Colorado Springs : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : Rose Breast Center
A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
Denver : The Urology Center of Colorado
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Denver : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : The Urology Center of Colorado
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denver : The Urology Center of Colorado
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Denver :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Denver : Rocky Mountain Cancer Centers - Denver Midtown
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Denver : Rocky Mountain Cancer Centers
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Denver : Rocky Mountain Cancer Centers
Safety Study of PLX108-01 in Patients With Solid Tumors
Denver : Kaiser Permanente
Tracking Renal Tumors After Cryoablation Evaluation
Englewood : Call for Information (Investigational Site 0304)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Fort Collins : Front Range Cancer Specialists
Dose-escalation Study of Oral CX-4945
Golden : Western Oncology/Hematology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lakewood : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lakewood :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Littleton : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Littleton :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Lone Tree : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Longmont : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Loveland : Front Range Cancer Specialists
Dose-escalation Study of Oral CX-4945
Parker : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Parker : Advanced Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pueblo : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Thornton : Rocky Mountain Cancer Centers
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Connecticut
Farmington : University of Connecticut Health Center
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Farmington : University of Connecticut Health Center - John Dempsey Hospital/Neag Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Middlebury : Connecticut Clinical Research Center, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
New Britain : Grove Hill Clinical Research, Grove Hill Medical Center, Urology Center of Grove Hill
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Haven : Yale University Comprehensive Cancer Center
A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer
View More »
New Haven :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
New Haven : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
New Haven : Yale University, Site #033
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
New Haven : The Urology Center, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Haven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
New Haven :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
New Haven : Yale University, Comprehensive Cancer Center
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
New Haven :
Sorafenib Long Term Extension Program (STEP)
New Haven : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Norwalk : Norwalk Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Norwich : Eastern Connecticut Hematology and Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Southington : 1200.75.10041 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Stamford : The Stamford Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stamford : Stamford Hospital
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Torrington : Call for Information (Investigational Site 0376)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Delaware
Newark : Call for Information (Investigational Site 0274)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Newark : Christiana Hospital
Breath Test for Early Detection of Lung Cancer
Newark : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
District of Columbia
Washington : Washington Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Washington : Howard University Cancer Center & Howeard University Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Washington : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Washington :
A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors
Washington : Call for Information (Investigational Site 0424)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
View More »
Washington : Call for Information (Investigational Site 0309)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Washington : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Washington : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Washington : Research Site
Panitumumab Pediatric Study
Washington : Investigational Site Number 840020
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Washington :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Florida
Atlantis : The Breast Institute at JFK Medical
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Aventura : South Florida Medical Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Aventura : Mount Sinai Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Aventura :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Boca Raton :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
View More »
Boynton Beach :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Boynton Beach : Call for Information (Investigational Site 0266)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Boynton Beach : Visions Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Boynton Beach : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Boynton Beach : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bradenton : Manatee Medical Research Institute, LLC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bradenton : Manatee Medical Research Institute, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Coral Gables : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Coral Gables : Call for Information (Investigational Site 0340)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Coral Gables : Call for Information (Investigational Site 0250)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Coral Gables : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Crestview : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Daytona Beach : Halifax Health Center for Oncology
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Fleming Island : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Meyers : Florida Urology Physicians
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Fort Myers : Florida Urology Physicians
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Fort Myers : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Myers : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
Fort Myers : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Fort Myers :
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Fort Myers : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Fort Myers :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Fort Myers : Regional Breast/21st Century Oncology
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Ft. Lauderdale :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Ft. Lauderdale : 1200.75.10028 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Gainesville : Malcom Randal VAMC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Gainesville : University of Florida College of Medicine
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
Hialeah : Call for Information (Investigational Site 0020)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Holiday : 1200.75.10029 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hollywood : 1200.75.10114 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hudson : Florida Cancer Specialists, PL
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jacksonville : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
Jacksonville : Call for Information (Investigational Site 0267)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Jacksonville : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Jacksonville : Mayo Clinic
Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia
Jacksonville : University of Florida Jacksonville
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Jacksonville : Investigational Site Number 840016
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Jacksonville Beach : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lake Worth : Altus Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Lakeland : Lakeland Regional Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Lakeland : Watson Clinic LLP, Center for Cancer Care & Research, Clark & Daughtrey Medical Group, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lakeland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Lakeland : Call for Information (Investigational Site 0384)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lynn Haven : Northwest Florida Hematology Oncology PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Miami : Advanced Medical Specialties
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Miami : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Miami : Call for Information (Investigational Site 0206)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0278)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0284)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0365)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0028)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0243)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Call for Information (Investigational Site 0268)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Miami : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Miami : University of Miami Sylvester Comprehensive Cancer Center
Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors
Miami : Call for Information (Investigational Site 0248)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Miami : Mount Sinai Medical Center-Miami
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Miami Beach : Mount Sinai Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Naples : Premier Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Naples : Specialists in Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Naples : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Port Richey : Florida Cancer Specialists, PL
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Port Richey :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Ocala : Ocala Oncology Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange City : Atlantic Urological Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orange City :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Orange Park : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Orlando : M.D. Anderson Cancer Center Orlando
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Orlando : Call for Information (Investigational Site 0419)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Orlando : Call for Information (Investigational Site 0429)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Orlando : MD Anderson Cancer Center
Breath Test for Early Detection of Lung Cancer
Orlando :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Palatka : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Pensacola : Sacred Heart Medical Oncology Groupl
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Plantation : 21st Century Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Plantation : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Port St. Lucie : Call for Information (Investigational Site 0259)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Sarasota :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Sarasota : Sarah Cannon Research Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Sarasota :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Sarasota : Florida Cancer Specialists
Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors
South Miami : Call for Information (Investigational Site 0247)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
St. Augustine : Integrated Community Oncology Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Petersberg : Pinellas Urology, Inc.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
St. Petersburg : Call for Information (Investigational Site 0006)
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
St. Petersburg : All Children's Hospital
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
St. Petersburg : Call for Information (Investigational Site 0006)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Stuart : Martin Health System
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Stuart : Call for Information (Investigational Site 0339)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Tallahassee : Southeastern Research Group, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tampa : H. Lee Moffitt Cancer Center and Research Institute
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Tampa : Moffitt Cancer Center & Research Institute
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Tampa : H. Lee Moffitt Cancer Center/University of South Florida Moffitt 4
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Tampa : Moffitt Cancer Center
Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
Tampa :
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Tampa : Moffitt Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Tampa : Call for Information (Investigational Site 0007) Updated
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Tampa : Moffitt Cancer Center
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
Tampa : Moffitt Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Tampa : Call for Information (Investigational Site 0004)
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)
Wellington :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
West Palm Beach : Palm Beach Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
West Palm Beach :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Winter Park :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Georgia
Alpharetta : Georgia Cancer Specialists - Alpharetta
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Athens : Georgia Cancer Specialists - Athens
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Athens : Northeast Georgia Cancer Care
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Athens :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Atlanta : Emory Winship Cancer Institute
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
View More »
Atlanta : Emory University School of Medicine
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Atlanta : AVEO Clinical Site
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
Atlanta : Emory University Hospital, The Emory Clinic, Winship Cancer Institute
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Peachtree Hematology-Oncology Consultants, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Piedmont West
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Atlanta Hematology Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Georgia Cancer Specialists - Emory Midtown
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Georgia Urology, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : Midtown Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Atlanta : Emory University
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Atlanta : Emory University, Winship Cancer Institute
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Atlanta : Emory University Winship Cancer Institute
A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
Atlanta : Call for Information (Investigational Site 0437)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Atlanta : St. Joseph's Hospital - Resurgeons Orthopedics
Bone Graft Materials Observational Registry
Atlanta : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Atlanta : Emory Crawford Long Hospital
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Grady Memorial Hospital
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Winship Cancer Institute of Emory University
Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
Atlanta : Pfizer Investigational Site
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
Atlanta :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Atlanta : Emory University Winship Cancer
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Atlanta : Emory University
Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Atlanta :
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors
Atlanta : Emory University
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Atlanta : Emory University Winship Cancer Institute
Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Atlanta : Investigational Site Number 840005
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Atlanta : Emory University Winship Cancer Institute
Re-expression of ER in Triple Negative Breast Cancers
Atlanta : Emory University
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Atlanta : Emory University
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Atlanta : Emory University Winship Cancer Institute
Study of Arsenic Trioxide in Small Cell Lung Cancer
Atlanta :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Atlanta : Emory University Winship Cancer Institute
Study of Everolimus (RAD001)in Combination With Lenalidomide
Atlanta : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Atlanta : Emory University Winship Cancer Institute
Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
Atlanta : Emory University Winship Cancer Institute
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Augusta : Investigational Site Number 840010
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Augusta : Augusta Oncology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Augusta : Georgia Health Sciences University
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Augusta : Investigational Site Number 840004
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Augusta : Investigational Site Number 840006
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Augusta : Investigational Site Number 840024
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Augusta : Investigational Site Number 1239
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Austell : Northwest Georgia Oncology Centers, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Carrollton : Northwest Georgia Oncology Centers, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cartersville : Northwest Georgia Oncology Centers, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Columbus : John B. Amos Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Decatur : Georgia Cancer Specialists - Stemmer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Decatur : Dekalb Medical Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Douglasville : Northwest Georgia Oncology Centers, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dublin : Call for Information (Investigational Site 0271)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Duluth : Suburban Hematology-Oncology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fayetteville : Georgia Cancer Specialists - Fayetteville
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Gainesville : Northeast Georgia Medical Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Lawrenceville : Suburban Hematology-Oncology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Macon : Georgia Cancer Specialists - Macon
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marietta : Georgia Cancer Specialists
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
Marietta : Northwest Georgia Oncology Centers, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marietta : Urology Enterprises
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marietta : Georgia Cancer Specialists - Kennestone
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marietta :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Marietta :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Riverdale : Southern Regional Medical Center
Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
Rome : Harbin Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sandy Springs : Georgia Cancer Specialists - Northside
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Savannah : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Snellville : Suburban Hematology-Oncology Associates, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stockbridge : Georgia Cancer Specialists - Stockbridge
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Stockbridge :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Thomasville : Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Hawaii
Honolulu : Call for Information (Investigational Site 0235)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Honolulu : 1200.75.10040 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Idaho
Coeur d'Alene : North Idaho Urology
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Illinois
Centralia : University Hematology Oncology, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Chicago : University of Chicago Comprehensive Cancer Center
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Chicago : University of Chicago Medical Center, Site #001
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Chicago : Site Reference ID/Investigator# 23284
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Chicago : Robert Lurie Comprehensive Cancer Center of Northwestern University
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
View More »
Chicago : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Chicago :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Chicago : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Chicago : Call for Information (Investigational Site 0024)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Chicago : Call for Information (Investigational Site 0454)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Chicago : Call for Information (Investigational Site 0023)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Chicago : Site Reference ID/Investigator# 26525
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Chicago : Center for Women
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Chicago : Northwestern Memorial Hospital
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Chicago : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Chicago : University of Chicago Comprehensive Cancer Center
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Chicago : University of IL at Chicago
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Chicago : Jesse Brown VA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Rush University Gastroenterologists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Stroger Cook County
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : University of Illinois at Chicago
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Chicago : Univeristy of Chicago
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Chicago :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Chicago : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Decatur : Call for Information (Investigational Site 0285)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Decatur : Investigational Site Number 840017
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Evanston :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Evanston : NorthShore University HealthSystem
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Galesburg : Medical & Surgical Specialists, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Galesburg :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Galesburg :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Glenview : Uropartners
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Glenview :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Gurnee :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Harvey : 1200.43.00113 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Joliet : Joliet Oncology-Hematology Associates, Ltd.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Joliet : Call for Information (Investigational Site 0407)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Joliet : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Kankakee : Urological Suregons of Illinois
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Maywood : Loyola University Chicago, Loyola University Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Maywood : Call for Information (Investigational Site 0273)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Maywood : Loyola University Medical Center
Umbilical Cord Transplantation for the Elderly Population
Melrose Park : Uropartners/RMD Clinical Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Melrose Park : UroPartners/RMD Clinical Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Melrose Park :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Naperville : DuPage Medical Group
Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Niles : Oncology Specialists, S.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Niles : Call for Information (Investigational Site 0018)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Niles :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Normal : Mid-Illinois Hematology & Oncology Associates, LTD
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Park Ridge : Oncology Specialists, S.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Peoria : Call for Information (Investigational Site 0277)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Peoria : 1200.43.00106 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Rockford : Call for Information (Investigational Site 0443)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Skokie : Call for Information (Investigational Site 0386)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Skokie : Call for Information (Investigational Site 0303)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Skokie : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Skokie : 1200.75.10031 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Springfield : Springfield Clinic
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Springfield : Southern Illinois University School of Medicine
A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Urbana : Call for Information (Investigational Site 0205)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Zion : Midwestern Regional Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Indiana
Anderson : Call for Information (Investigational Site 0025)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Anderson : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Avon : Call for Information (Investigational Site 0257)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Elkhart : Elkhart Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Elkhart : Elkhart General Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Evansville : Urological Associates, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Evansville : Call for Information (Investigational Site 0011)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Fort Wayne : Fort Wayne Medical Oncology and Hematology, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Wayne : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Indianapolis :
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Indianapolis : ImClone Investigational Site
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Indianapolis : Call for Information (Investigational Site 0427)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Indianapolis :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Indianapolis : Indiana University School of Medicine
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Indianapolis : Quality Oncology Care, Inc.
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Indianapolis : Community Regional Cancer Center-Community Hospital North
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Indianapolis : Call for Information (Investigational Site 0233)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Indianapolis : IUPUI
Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Indianapolis : Investigational Site Number 840022
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Indianapolis : Indiana University Cancer Center
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Indianapolis : Indiana University Simon Cancer Center
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Indianapolis :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Indianapolis : Indiana University Melvin and Bren Simon Cancer Center
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
Indianapolis : Indiana University Simon Cancer Center
Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated
Jeffersonville : First Urology PSC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Jeffersonville : Metropolitan Urology Clinical Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jeffersonville : Metropolitan Urology Clinical Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Jeffersonville :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Kokomo : Call for Information (Investigational Site 0442)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lafayette : Horizon Oncology Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Lafayette : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Lafayette :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Lafayette : Horizon Oncology Research, Inc.
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
LaPorte : Indiana University Health La Porte Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Martinsville : Morgan Hospital and Medical Center
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Mishawaka : Saint Joseph Regional Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Albany : Call for Information (Investigational Site 0396)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
New Albany : 1200.75.10025 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Plymouth : Michiana Hematology Oncology, P. C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
South Bend : Northern Indiana Cancer Research Consortium
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
South Bend : Memorial Hospital of South Bend
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
South Bend : Northern Indiana Cancer Research Consortium, Michiana Hematology Oncology, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
South Bend : Call for Information (Investigational Site 0395)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
South Bend : Northern Indiana Cancer Research Consortium
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Westville : Michiana Hematology Oncology, P. C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Iowa
Ames : McFarland Clinic, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Ames : Call for Information (Investigational Site 0249)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Ames : McFarland Clinic
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Cedar Rapids : Physician's Clinic of Iowa, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cedar Rapids : Call for Information (Investigational Site 0286)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
View More »
Cedar Rapids : Call for Information (Investigational Site 0360)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Council Bluffs : Heartland Oncology & Hematology, PLLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Des Moines : Call for Information (Investigational Site 0197)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Iowa City : University of Iowa Hospitals and Clinics
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Iowa City : University of Iowa Hospitals and Clinics
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Iowa City : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Iowa City : Holden Comprehensive Cancer Center
Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
Sioux City : Siouxland Hematology Oncology Associates
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Waterloo : Call for Information (Investigational Site 0382)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Waterloo : 1200.75.10020 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Waterloo : Covenant Medical Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
West Des Moines : The Iowa Clinic, PC Iowa Urology
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
West Desmoines : The Iowa Clinic
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Kansas
Fairway : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
Fairway : University of Kansas Cancer Center
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Fairway : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
Kansas City : University of Kansas Cancer Center Medical Center
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
Kansas City : University of Kansas Medical Center
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
View More »
Kansas City : Investigational Site Number 840001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Overland Park : Kansas City Urology Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Westwood : University of Kansas Medical Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Westwood :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Wichita : Cancer Center of Kansas
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Wichita : Call for Information (Investigational Site 0199)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Wichita : Call for Information (Investigational Site 0015) Updated
A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025 AM3)
Wichita : Cancer Center of Kansas
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Wichita : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Wichita :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Kentucky
Ashland :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bardstown : Call for Information (Investigational Site 0228)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Hazard :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Lexington : University of Kentucky
Tracking Renal Tumors After Cryoablation Evaluation
Louisville : Owlsey Brown Frazier Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Louisville : University of Louisville James Brown Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Paducah : Call for Information (Investigational Site 0283)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Paducah : Call for Information (Investigational Site 0269)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Paducah : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Louisiana
Baton Rouge : Ochsner Clinic - Baton Rouge
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Baton Rouge : Gastroenterology Associates
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Bossier :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Covington : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Covington : Call for Information (Investigational Site 0310)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
View More »
Crowley : Louisiana Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lafayette : Louisiana Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Marrero : Call for Information (Investigational Site 0249)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Metairie : Call for Information (Investigational Site 0275)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Metairie : Investigational Site Number 840003
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
New Iberia : Louisiana Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Orleans : Ochsner Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
New Orleans : Tulane University
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
New Orleans : Ochsner Clinic Foundation
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Orleans : Tulane University Health Sciences Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Orleans : Ochsner Clinic Foundation
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
New Orleans : Call for Information (Investigational Site 0200)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
New Orleans : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
New Orleans :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
New Orleans : 1200.75.10019 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New Orleans : 1200.131.00187 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
New Orleans : Tulane University Medical School
Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer
New Orleans :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Opelousas : Louisiana Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Shreveport : Northwest Louisiana Oncology Associates Of Highland Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Shreveport :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Maine
Lewiston : Call for Information (Investigational Site 0293)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Scarborough : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Maryland
Annapolis : Call for Information (Investigational Site 0397)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Baltimore : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Baltimore : Greater Baltimore Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Baltimore : Union Memorial Hospital
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Baltimore : Site Reference ID/Investigator# 7180
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
View More »
Baltimore : Chesapeake Urology Research Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Baltimore : University of MD Greenbaum Cancer Center
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Baltimore : University of Maryland Greenebaum Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
A Study of of MORAb-004 in Subjects With Solid Tumors
Baltimore :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Baltimore :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Baltimore : The Sidney Kimmel Comprehensive Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Baltimore : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Baltimore : Call for Information (Investigational Site 0247)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Baltimore : Call for Information (Investigational Site 0302)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Baltimore : Call for Information (Investigational Site 0400)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Baltimore : Call for Information (Investigational Site 0318)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Baltimore : Site Reference ID/Investigator# 58883
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Baltimore : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Baltimore : 1200.75.10030 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Baltimore : 1200.131.00173 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Baltimore : University of Maryland Greenebaum Cancer Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Baltimore : Investigational Site Number 840013
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Baltimore : Investigational Site Number 840019
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Baltimore : Kimmel Comprehensive Cancer Center
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Baltimore :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Baltimore : University of Maryland Marlene & Stewart Greenebaum Cancer Center
Study of How Well Letrozole Works in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
Baltimore : Saint Agnes Healthcare
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Baltimore : Weinberg Cancer Institution at Franklin Square
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Bethesda : Walter Reed Army Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bethesda : National Cancer Institute - Center for Cancer Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bethesda : Call for Information (Investigational Site 0012)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bethesda : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Bethesda : Investigational Site Number 840007
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Bethesda : 1200.75.10038 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bethesda : Center for Cancer and Blood Disorders
Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Bethesda : NCI, CCR
Open Label Study to Evaluate the Safety and Tolerability of GI-6301 a Vaccine Consisting of Whole Heat-Killed Recombitant Yeast Genetically Modified to Express Brachyury Protein in Adults With Solid Tumors
Bethesda :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Bethesda : Bethesda Naval Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Chevy Chase : Chevy Chase Clinical Research
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Cumberland : Western Maryland Health System
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Elkridge : Call for Information (Investigational Site 0242)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Frederick : Call for Information (Investigational Site 0279)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Greenbelt : Myron I Murdock MD LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Greenbelt : Myron I. Murdock MD, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Rockville : Call for Information (Investigational Site 0016) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Rockville :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Westminster : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Massachusetts
Boston : Massachusetts General Hospital Mass Gen 2
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Boston : Call for Information (Investigational Site 0003)
A Dose Escalation Study of MK1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001 AM7)
Boston : Dana-Farber Cancer Institute
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
Boston : Mass General Hospital (MGH), Site #047
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
View More »
Boston : Beth Israel Deaconess Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Boston : Dana Farber Cancer Institute
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Boston : Investigational Site Number 840001
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
Boston : Massachusetts General Hospital CCPO
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Boston : Massachusetts General Hospital Mass General 2
A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors
Boston : Call for Information (Investigational Site 0007) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Boston : Call for Information (Investigational Site 9103) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Boston : Call for Information (Investigational Site 0009) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Boston : Tufts Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Boston : Dana-Farber Cancer Institute
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Boston : Steward Sr. Elizabeth's Medical Center of Boston Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Boston : Dana Farber Cancer Institute
A Safety Study of Oral ZSTK474 in Patients With Cancer
Boston : Dana-Farber / BIDMC / Harvard Cancer Center
A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
Boston :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors
Boston : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Boston : ImClone Investigational Site
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Boston : Beth Israel Deaconess Medical Center (BIDMC)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Boston : Dana Farber Cancer Institute (DFCI)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Boston : Investigational Site Number 840001
A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Boston : Investigational Site Number 840101
A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Boston : Dana Farber Cancer Institute SC
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Boston :
A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors
Boston : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Boston : Dana-Farber Cancer Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Boston : Dana Farber Cancer Institute
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Boston :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Boston : Dana-Farber Cancer Institute
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Boston : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Boston :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
Boston : Tufts-New England Medical Center
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
Boston : Dana Farber Cancer Institute DFCI
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Boston : BWH
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Boston : Site Reference ID/Investigator# 58882
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Boston : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Boston : Investigational Site Number 840002
Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Boston : Dana Farber Cancer Institute
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Boston : Beth Israel Deaconess Medical Center`
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Dana-Farber Cancer Institute
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston : Massachusetts General Hospital
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Boston :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Boston : Massachusetts General Hospital / Dana Farber Cancer Institute
E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)
Boston : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Boston : Beth Israel Deaconess Medical Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Dana-Farber Cancer Institute
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Boston : Massachusetts General Hospital Updated
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors
Boston :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Boston : 1200.43.00110 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Boston : 1200.131.00176 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Boston : 1200.131.00190 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Boston : Beth Israel Deaconess Medical Center
MSC2015103B in Solid Tumors
Boston : Dana-Farber Cancer Institute
MSC2015103B in Solid Tumors
Boston : Investigational Site Number 840004
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Boston : Dana-Farber Cancer Institute
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Boston : Beth Israel Deaconess Medical Center
Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Boston : Investigational Site Number 840012
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Boston : Dana-Farber Cancer Institute
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Boston : Beth Israel Deaconess Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Dana Farber Cancer Institute
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Massachusetts General Hospital
Safety Study of PLX108-01 in Patients With Solid Tumors
Boston : Massachusetts General Hospital Mass General 2
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Boston : Massachusetts General Hospital Mass General 2
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Boston :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Boston : Synta Pharmaceutials Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Boston : Dana Farber Cancer Institute Deptof DanaFarberCancerInst(5)
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Boston : Call for Information (Investigational Site 0002)
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)
Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Massachusetts General Hospital Cancer Center
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Dana Farber Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Boston : Investigational Site Number 1133
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Boston : Massachusetts General Hospital
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Boston : Dana Farber Cancer Institute
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Brockton : Commonwealth Clinical Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Pittsfield :
Combination With Gemcitabine in Advanced Pancreatic Cancer
Rockland : For Recruiting Locations in the US contact US Medical Information in
Combination Trial MSC1936369B With Temsirolimus
Michigan
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
Ann Arbor : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Ann Arbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
View More »
Ann Arbor : University of Michigan Comprehensive Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Ann Arbor : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
Ann Arbor : University of Michigan Cancer Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Ann Arbor : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Ann Arbor : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Ann Arbor : Investigational Site Number 840010
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Ann Arbor : University of Michigan
Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone
Brownstown : Henry Ford Medical Center - Woodhaven
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dearborn : Henry Ford Medical Center - Fairlane
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dearborn : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Detriot : Barbara Ann Karmanos Cancer Center
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies
Detriot : Karmanos Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Detriot : The Karmanos Cancer Institute
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Detriot : Wayne State University Karmanos Cancer Institute
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Detroit : Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6)
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Detroit : ImClone Investigational Site
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Detroit :
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Detroit :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Detroit : Karmanos Cancer Institute
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Detroit : Karmanos Cancer Institute
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Detroit : Henry Ford Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Detroit : Karmanos Cancer Institute
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Detroit :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Detroit :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors
Detroit : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Detroit : Karmanos Cancer Center
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Detroit : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Detroit : Wayne State University Department of Oncology Karmanos Cancer Institute
A Study of DS-2248, in Subjects With Advanced Solid Tumors
Detroit : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
Detroit : Wayne State University/Karmanos Cancer Institute Wayne St
A Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Detroit : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Detroit : Karmanos Cancer Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Detroit : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
Detroit : Karmanos Cancer institute
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Detroit : Investigational Site Number 840001
A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma
Detroit :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
Detroit : ImClone Investigational Site
A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI
Detroit : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Detroit : Call for Information (Investigational Site 0229)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Detroit : Pfizer Investigational Site
A Trial In Patients With Advanced Cancer And Leukemia
Detroit : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Detroit : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Detroit : Investigational Site Number 840001
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Detroit : Karmanos Cancer Institute
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Detroit : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Detroit : Barbara Ann Karmanos Cancer Institute Updated
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors
Detroit : Karmanos Cancer Institute
MSC2015103B in Solid Tumors
Detroit : Investigational Site Number 840001
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Detroit : Karmanos Cancer Institute
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Detroit : Karmanos Cancer Institute
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Detroit : Wayne State (Karmanos Cancer Institute)
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Detroit : Investigational Site Number 840004
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Detroit : Karmanos Cancer Institute
Safety Study of AB0024 in Patients With Advanced Solid Tumors
Detroit : Wayne State University/Karmanos Cancer Institute Study Coordinator
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Detroit : Site Reference ID/Investigator# 57555
Study of ABT-700 in Subjects With Advanced Solid Tumors
Detroit : Karmanos Cancer Institute
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Detroit :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Detroit :
Study of GDC-0973/XL518 in Patients With Solid Tumors
Detroit : Barbara Ann Karmanos Cancer Institute
Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
Detroit : Karmanos Cancer Institute
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Detroit : Wayne State University/Karmanos Cancer Institute
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Detroit : Investigational Site Number 1326
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Detroit : Karmanos Cancer Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Detrot :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Farmington Hills : Karmanos Cancer Institute at Farmington Hills
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Grand Rapids : Spectrum Health Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Grand Rapids : Spectrum Health / Advanced Radiology Services
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Lansing : Call for Information (Investigational Site 0383)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lansing :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Niles : Lakeland Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Novi : Henry Ford Medical Center - Columbus Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Southfield : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Southfield : PRESSD
Bone Graft Materials Observational Registry
St. Clair Shores : Michgan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Joseph : Lakeland Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Joseph : Marie Yeager Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Troy : Michigan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Utica : Michigan Institute of Urology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Warren : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
West Bloomfield : Henry Ford Medical Center- West Bloomfield
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minnesota
Burnsville : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Coon Rapids : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Duluth : Call for Information (Investigational Site 0282)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Duluth : 1200.75.10005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Edina : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Fridley : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Maplewood : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minneapolis : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minneapolis : University Of Minnesota
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Minneapolis : University of Minnesota
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Minneapolis : Call for Information (Investigational Site 0022)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Minneapolis : Research Site
Panitumumab Pediatric Study
Minneapolis : Novartis Investigative Site
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Minneapolis :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Robbinsdale : Hubert H. Humphrey Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rochester : Mayo Clinic
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 in Patients With Advanced Cancer
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2875358 in Patients With Advanced Cancer
Rochester : Mayo Clinic
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Rochester : Mayo Clinic
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Rochester :
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Rochester : Investigational Site Number 840007
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Sartell : Adult and Pediatric Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Cloud : Call for Information (Investigational Site 0202)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
St. Paul : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Woodbury : Minnesota Oncology Hematology, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Mississippi
Jackson :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
New Albany : The Jones Clinic, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Oxford : Family Cancer Center Foundation, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Southaven : Family Cancer Center Foundation, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tupelo : 1200.75.10015 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Missouri
Bridgeton : St. Louis Cancer Care, LLP
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Chesterfield : St. Louis Cancer Care, LLP
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Columbia : Ellis Fischel Cancer Center - University of Missouri Health Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Jefferson City :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Kansas City : Saint Luke's Cancer Institute, Saint Luke's Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Kansas City : Research Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Kansas City : Children's Mercy Hospital & Clinics
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Kansas City : Call for Information (Investigational Site 0229)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Kansas City : Department of Veterans Affairs Medical Center
The Study of Barrett's Esophagus: What Are the Factors of Progression
Saint Louis : Call for Information (Investigational Site 0150)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Saint Louis : Call for Information (Investigational Site 0294)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Saint Louis : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Springfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Springfield : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
St Louis : Investigational Site Number 840007
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
St Louis : Washington University
A Safety Study of Oral ZSTK474 in Patients With Cancer
St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
St Louis :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
St Louis : Washington University
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
St Louis : Investigational Site Number 840001
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
St Louis : Investigational Site Number 840003
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
St. Louis : Siteman Cancer Center, Washington University School of Medicine
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
St. Louis : Comprehensive Cancer Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Louis : St. Louis Cancer Care, LLP
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
St. Louis : Washington University School of Medicine, Siteman Cancer Center
Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors
St. Louis :
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
St. Louis :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Montana
Billings : Billings Clinic Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Billings : Call for Information (Investigational Site 0368)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Billings : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Great Falls : Call for Information (Investigational Site 0378)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Missoula :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
View More »
Missoula : Call for Information (Investigational Site 0349)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Missoula : Montana Neuroscience Institute Foundation
Bone Graft Materials Observational Registry
Nebraska
Lincoln : Nebraska Hematology-Oncology, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC / Southeast Nebraska Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lincoln : Call for Information (Investigational Site 0240)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lincoln : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Lincoln :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
View More »
Omaha : Urology Cancer Center and GU Research Network
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Omaha : GU Research Network, LLC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Omaha : Oncology Hematology West, PC dba Nebraska Cancer Specialists
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Omaha : Urology Cancer Center & GU Research Network
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Omaha : Call for Information (Investigational Site 0256)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Omaha :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Omaha : Missouri Valley Cancer Consortium
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Omaha : 1200.43.00107 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Omaha : 1200.131.00182 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Omaha :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Omaha : University of Nebraska
Tracking Renal Tumors After Cryoablation Evaluation
Nevada
Henderson : Comprehensive Cancer Centers of Nevada
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Las Vegas : ImClone Investigational Site
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Las Vegas : Comprehensive Cancer Centers of Nevada
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Las Vegas : Comprehensive Cancer Centers of Nevada
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
View More »
Las Vegas : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
Las Vegas : ImClone Investigational Site
A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI
Las Vegas : Call for Information (Investigational Site 0387)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Las Vegas : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Las Vegas : Comprehensive Caner Centers of Nevada/Summerlin Hospital
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Las Vegas : Comprehensive Cancer Centers of Nevada
Safety Study of PLX108-01 in Patients With Solid Tumors
Las Vegas :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Reno : VA Sierra Nevada HealthCare System
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Reno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
New Hampshire
Dover : Call for Information (Investigational Site 0204)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lebanon : Call for Information (Investigational Site 0050) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Lebanon : Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lebanon : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Lebanon : 1200.131.00175 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
View More »
Lebanon : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Manchester : Call for Information (Investigational Site 9107) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
New Jersey
Berlin :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Berlin :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bloomfield : New Jersey Urology, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Camden : Call for Information (Investigational Site 0448)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Cherry Hill : Investigational Site Number 840010
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View More »
Denville : Oncology and Hematology Specialists, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Denville : Call for Information (Investigational Site 0196)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Hackensack : Research Site
AMG 319 Lymphoid Malignancy FIH
Hackensack : Hackensack University Medical Center
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Hackensack : Hackensack University Medical Center
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Lawrenceville : Premier Urology Associates, LLC / AdvanceMed Research
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Lawrenceville :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Morristown : Hematology-Oncology Associates of Northern NJ, PA; Carol G. Simon Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Morristown : Morristown Memorial Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Mt. Laurel : Delaware Valley Urology, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Brunswick : Call for Information (Investigational Site 0014) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
New Brunswick : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
New Brunswick : Investigational Site Number 840002
A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma
New Brunswick : GSK Investigational Site
Dose-Escalation Study of GSK2126458
New Brunswick : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
New Brunswick : Investigational Site Number 840002
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
New Brunswick : Cancer Institute of New Jersey Dept of Cancer Institute of NJ
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
New Brunswick : The Cancer Institute of New Jersey
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
New Brunswick : Cancer Institute of New Jersey
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Newark : Newark Beth Israel Medical Center, Cancer and Blood Disorders Center, Frederick B. Cohen, MD
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Newark : Investigational Site Number 840006
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Somerville : Call for Information (Investigational Site 0327)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Sparta : Sparta Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Teaneck : Holy Name Medical Center
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Teaneck : 1200.75.10002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New Mexico
Albuquerque : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Albuquerque : New Mexico Oncology Hematology Consultants, LTD
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Albuquerque : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Santa Fe : New Mexico Cancer Care Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York
Albany : New York Oncology Hematology, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Albany : Albany Medical Center
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Albany :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Albany :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Bronx : Albert Einstein Cancer Center at the Montefiore Medical Park
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Bronx : Eastchester Center for Cancer Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bronx : Montefiore Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bronx :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Bronx : Montefiore Medical Center
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Bronx : Montefiore Medical Center
Safety Study of Live Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Brooklyn : Brooklyn Urology Research Group
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Brooklyn :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Buffalo : The Jonah Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Buffalo : Zale P. Bernstein, MD, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Buffalo : Roswell Park Cancer Institute
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Buffalo :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Buffalo :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Buffalo : Roswell Park Cancer Institute
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Buffalo :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Buffalo : Roswell Park Cancer Institute
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Commack : Call for Information (Investigational Site 0263)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
East Setaukey : North Shore Hematology/Oncology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
East Syracuse : Call for Information (Investigational Site 0033)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Fresh Meadows : Queens Medical Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Garden City :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Garden City :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Great Neck : Call for Information (Investigational Site 0258)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Great Neck : Call for Information (Investigational Site 0234)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Great Neck : Long Island Gastrointestinal Group
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Great Neck : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Lake Success : Monter Cancer Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Lake Success : Call for Information (Investigational Site 0230)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lake Success : 1200.75.10044 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Lake Success : 1200.67.10003 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Lake Success : North Shore University Hospital-Monter Cancer Center
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Manhasset : Call for Information (Investigational Site 0233)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Manhasset : North Shore University Hospital
Magnetic Resonance Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors
Mineola : Winthrop University
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
New York : Memorial Sloan Kettering Cancer Center
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
New York : Memorial Sloan Kettering Cancer Center
A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene
New York :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
New York : Columbia University Medical Center
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
New York : University Urology Associates
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
New York : NYU Clinical Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York : NYU Langone Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York : University Urology Associates
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New York : Site Reference ID/Investigator# 23282
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
New York : ImClone Investigational Site
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
New York : Memorial Sloan-Kettering Cancer Center
A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
New York : Memorial Sloan Kettering Cancer Center
A Study of of MORAb-004 in Subjects With Solid Tumors
New York : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
New York :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
New York : Memorial Sloan Kettering Cancer Center
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
New York :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
New York : Memorial Sloan Kettering Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
New York : Research Site
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
New York : Call for Information (Investigational Site 0370)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
New York : Call for Information (Investigational Site 0408)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
New York : Call for Information (Investigational Site 0409)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
New York : Memorial Sloan Kettering Cancer Center MSKCC (2)
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
New York : New York Downtown Hospital
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
New York : Mount Sinai
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
New York : Memorial Sloan Kettering Cancer Center
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
New York : New York University Medical Center
Breath Test for Early Detection of Lung Cancer
New York : Memorial Sloan-Kettering Cancer Center
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
New York : Memorial Sloan Kettering Cancer Center
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
New York : Memorial Sloan-Kettering Cancer Center
HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET
New York :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
New York : 1200.75.10008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New York : 1200.75.10027 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
New York : Mount Sinai School of Medicine
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
New York : Research Site
Panitumumab Pediatric Study
New York : Mount Sinai Medical Center
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
New York : Investigational Site Number 840009
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
New York : NYU Cancer Center
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
New York : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Memorial Sloan-Kettering Cancer Center (MSKCC)
Safety Study of PLX108-01 in Patients With Solid Tumors
New York : Memorial Sloan Kettering Cancer Center MSKCC (2)
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
New York : Memorial Sloan-Kettering Cancer Center
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
New York :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
New York : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
New York :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
New York : Memorial Sloan-Kettering Cancer Center
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
New York : Memorial Sloan-Kettering Cancer Center
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
New York : Memorial Sloan-Kettering Cancer Center
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
New York : Columbia University
Tracking Renal Tumors After Cryoablation Evaluation
New York : Melanoma and Sarcoma Service / Memorial Sloan Kettering Cancer Center
Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors
New York city : Department of Radiation oncology, Memorial Sloan Kettering Cancer Center
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Port Jefferson :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Poughkeepsie : Hudson Valley Urology, P.C.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Poughkeepsie : Premier Medical Group of the Hudson Valley
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Poughkeepsie : Premier Medical Group of the Hudson Valley
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Poughkeepsie :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Rochester : University of Rochester Wilmont Cancer Center
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Rochester : University of Rochester Medical Center, James P. Wilmot Cancer Center
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Rochester : University of Rochester Medical Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Rochester : Call for Information (Investigational Site 0198)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Rochester : Call for Information (Investigational Site 0241)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Staten Island : Staten Island Urological Research, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Staten Island : Staten Island Urological Research, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Staten Island :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Stony Brook : 1200.43.00105 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Stony Brook : 1200.131.00179 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Stony Brook : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Syracuse : Associated Medical Professionals of New York, PLLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Syracuse : Syracuse Orthopedic Specialists
Bone Graft Materials Observational Registry
Williamsville : Windsong Comprehensive Breast Care
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Zion : 1200.67.10109 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
North Carolina
Asheville : Asheville Hematology & Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Asheville : 1200.75.10110 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Asheville : Asheville Gastroenterology
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Boone : Seby B. Jones Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Burlington : Alamance Regional Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
View More »
Cary : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Chapel Hill : UNC/Lineberg Comprehensive Cancer Center Lineberger Comp Cancer Ctr
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Chapel Hill : University of North Carolina - Chapel Hill
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Chapel Hill : University of North Carolina, Chapel Hill
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Chapel Hill : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Chapel Hill :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Chapel Hill : UNC - Chapel Hill
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Chapel Hill :
Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor BAY80-6946 With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Chapel Hill : University of North Carolina
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Chapel Hill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Charlotte : Presbyterian Hospital Center for Cancer Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Charlotte : Blumenthal Cancer Center - Main
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Charlotte : Carolinas Medical Center
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Charlotte : Carolinas Hematology-Oncology Associates
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Charlotte : Call for Information (Investigational Site 0014)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Charlotte : Carolinas HealthCare System
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Concord : Northeast Urology Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Durham : Research Site
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Durham : Durham VA Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Durham : Regional Cancer Care PA
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Durham : Duke University Medical Center - Duke South Clinics
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Durham : Regional Cancer Care, P.A.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Durham : Duke University Medical Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Durham :
A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors
Durham : 1200.89.10005 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Durham : Research Site
AMG 319 Lymphoid Malignancy FIH
Durham : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Durham : Duke Cancer Institute
Dose Escalation Study of Pazopanib Plus TH-302
Durham : Duke University Medical Center
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
Durham : Duke University Medical Center
Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Durham : Duke University Medical Center
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Durham : Duke University Medical Center
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
Durham : Site Reference ID/Investigator# 66111
Study of ABT-700 in Subjects With Advanced Solid Tumors
Durham :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Fayetteville : Cape Fear Valley Health System
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fayetteville : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Gastonia : Carolina Urology Partners
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Gastonia : Call for Information (Investigational Site 0375)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Goldsboro : Southeast Medical Oncology Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Greensboro : Alliance Urology Specialists, PA
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Greensboro : The Moses Cone Regional Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Greensboro : The Moses H. Cone Regional Cancer Center
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Greenville : Leo W. Jenkins Cancer Center at ECU Medical School
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
High Point : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Huntersville :
A Study of MPDL3280A in Combination With Avastin (Bevacizumab) or With Avastin Plus Chemotherapy in Patients With Advanced Solid Tumors
Huntersville : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
New Bern : Coastal Carolina Health Care, PA, dba New Bern Cancer Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
New Bern : New Bern Cancer Care, PA
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Pinehurst, : First Health of the Carolinas, Moore Regional Hospital
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Raleigh : Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Raleigh : Rex Cancer Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Raleigh :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Raleigh : Rex Cancer Center at Rex Hospital
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Raleigh :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Rocky Mount : Nash Health Care Systems
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Washington : Marion L. Shepard Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Wilmington : Call for Information (Investigational Site 0432)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Winston Salem : University of Wake Forest Baptist Medical Center
Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Winston-Salem :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Winston-Salem : Call for Information (Investigational Site 0315)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Winston-Salem :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Winston-Salem : Wake Forest University Comprehensive Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Winston-Salem : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
North Dakota
Bismarck : St. Alexius Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bismarck : Call for Information (Investigational Site 0030)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bismarck : Call for Information (Investigational Site 0224)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bismarck : Call for Information (Investigational Site 0305)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bismarck : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
View More »
Bismarck :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Bismarck :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Bismark :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Fargo : Call for Information (Investigational Site 0153)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Fargo : Call for Information (Investigational Site 0301)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Ohio
Akron : Call for Information (Investigational Site 0323)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Akron : Call for Information (Investigational Site 0250)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Canton : Gabrail Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Canton : Call for Information (Investigational Site 0422)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Canton : Gabrail Cancer Center Research
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
View More »
Canton : 1200.75.10021 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Canton : Investigational Site Number 840011
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Canton : Investigational Site Number 840021
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Cincinnati : Investigational Site Number 840001
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Cincinnati : University of Cincinnati Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Cincinnati : TriState Urologic Services PSC, Inc. dba TUG Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cincinnati : Division of Urology
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Cincinnati : Investigational Site Number 840004
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Cincinnati : Investigational Site Number 840002
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
Cincinnati :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Cincinnati : 1200.75.10026 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Cincinnati : Call for Information (Investigational Site 0231)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Cincinnati : Investigational Site Number 840007
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Cincinnati :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Cleveland : Research Site
A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumor
Cleveland : Cleveland Clinic Foundation
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Cleveland : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Cleveland : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
Cleveland : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
Cleveland : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Cleveland :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Cleveland : Case Western Reserve University, University Hospitals of Cleveland
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : Cleveland Clinic, Taussig Cancer Institute
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy
Cleveland : University Hospitals of Cleveland
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
Cleveland : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Cleveland :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Cleveland : Cleveland Clinic
The Study of Barrett's Esophagus: What Are the Factors of Progression
Columbus : Columbus Urology Research
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Columbus : Ohio State University Comprehensive Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Columbus : The Ohio State University Comprehensive Cancer Center
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Columbus : ImClone Investigational Site
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Columbus : Columbus Urology Research, LLC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Columbus :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Columbus : Call for Information (Investigational Site 0019)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Columbus : Ohio State University Comprehensive Cancer Center - The James
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Columbus : 1200.67.10004 Boehringer Ingelheim Investigational Site
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
Columbus : Ohio State University Comprehensive Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Columbus : The Ohio State University
Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
Columbus : The Ohio State University - Comprehensive Cancer Center
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
Columbus : Investigational Site Number 1325
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Dover : Gabrail Cancer Center Research
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Kettering : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Middleburg Heights : SouthWest Urology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Middletown : Investigational Site Number 840019
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Middletown : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toledo : Call for Information (Investigational Site 0399)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Oklahoma
Altus : Cancer Centers of Southwest Oklahoma
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Duncan : Cancer Centers of Southwest Oklahoma
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lawton : Cancer Centers of Southwest Oklahoma
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Oklahoma City : University of Oklahoma Health Sciences Center
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
View More »
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3023414 in Participants With Advanced Cancer
Oklahoma city :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Oklahoma City : Call for Information (Investigational Site 0325)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Oklahoma City : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Oklahoma City :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Oklahoma City : University of Oklahoma
Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors
Oklahoma City : University of Oklahoma Stephenson Cancer Center Updated
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors
Oklahoma City : Peggy and Charles Stephenson Oklahoma Cancer Center
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
Oklahoma City : Peggy and Charles Stephens Oklahoma Cancer Center
Safety Study of X-82 in Patients With Advanced Solid Tumors
Oklahoma City : Oklahoma University
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Oklahoma City : Investigational Site Number 1434
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oklahoma City : Univ. Oklahoma Health Science Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Tulsa : Urologic Specialists of Oklahoma
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tulsa : Tulsa Cancer Institute
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Oregon
Beaverton : Call for Information (Investigational Site 0401)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bend : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Eugene :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Portland : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Portland : Providence Cancer Center Oncology and Hematology Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Portland : Oregon Health & Science University
Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
Portland : Oregon Health & Science University OHSU 3
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Portland : Northwest Gastroenterology Clinic, LLC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Portland : Research Site
Panitumumab Pediatric Study
Portland : Oregon Health & Science University
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Portland : Oregon Health and Sciences University
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Cancer Center
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas
Portland : Providence Portland Med Ctr
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Portland : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Portland : Oregon Health and Science University
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Springfield : Willamette Valley Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Springfield : Oregon Urology Institute
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tualatin : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tualatin : Legacy Meridian Park Medical Center
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Pennsylvania
Abington : Pfizer Investigational Site
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Abington : Investigational Site Number 1132
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Allentown : Breast Care Specialist, PC
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Bala Cynwyd : Urologic Consultants of Southeaster PA LLP
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bala Cynwyd : Urologic Consultants of SE PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
View More »
Bala Cynwyd : Urology Consultants of Southeastern Pennsylvania
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Bethlehem : Call for Information (Investigational Site 0417)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Bethlehem : Investigational Site Number 840010
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Bryn Mawr : Urology Health Specialists, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Carnegie : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Easton : St. Luke's Hospital and Health Network
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Erie : The Regional Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Gettysburg : Gettysburg Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lancaster : Urological Associates Of Lancaster
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Lancaster : Urological Associates of Lancaster
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lancaster : Urological Associates of Lancaster
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Lancaster :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Lancaster :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Lemoyne : 1200.75.10018 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Philadelphia : University of Pennsylvania
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Philadelphia :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Philadelphia : University of Pennsylvania, Site #013
A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Philadelphia : Site Reference ID/Investigator# 6344
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Philadelphia : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Philadelphia : Fox Chase Cancer Center
A Safety Study of Oral ZSTK474 in Patients With Cancer
Philadelphia : Site Reference ID/Investigator# 23286
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Philadelphia : Thomas Jefferson University Hospital
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Philadelphia : Research Site
A Study of AMG 820 in Subjects With Advanced Solid Tumors
Philadelphia : University of Pennsylvania Abramson Cancer Center
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Philadelphia : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
Philadelphia :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Philadelphia :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Philadelphia : ImClone Investigational Site
A Study to Assess the Pharmacokinetics of Ramucirumab in Combination With FOLFIRI
Philadelphia :
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Philadelphia : Call for Information (Investigational Site 0021)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Philadelphia : Call for Information (Investigational Site 0026)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Philadelphia : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Philadelphia : Investigational Site Number 840002
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Philadelphia : Hospital of the University of Pennsylvania
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Philadelphia :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Philadelphia :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Philadelphia : 1200.75.10035 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Philadelphia : 1200.75.10048 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Philadelphia : 1200.43.00103 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Philadelphia : 1200.43.00102 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Philadelphia : 1200.131.00172 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Philadelphia :
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Philadelphia : Fox Chase Cancer Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Philadelphia : Pennsylvania Oncology Hematology Associates
Safety Study of PLX108-01 in Patients With Solid Tumors
Philadelphia : University of Pennsylvania
Safety Study of PLX108-01 in Patients With Solid Tumors
Philadelphia : Hospital Of The University Of Pennsylvania
Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Philadelphia :
Sorafenib Long Term Extension Program (STEP)
Philadelphia : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Philadelphia : Fox Chase Cancer Center
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Philadelphia : Investigational Site Number 1134
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Philadelphia : Fox Chase Cancer Center
Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer
Philadelphia : Fox Chase Cancer Center
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Philadelphia : Pennsylvania Oncology
Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Subjects With Solid Tumors
Philadelphia : Thomas Jefferson University
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Pittsburgh : ImClone Investigational Site
A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin
Pittsburgh : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
Pittsburgh :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
Pittsburgh : UPMC Shadyside Radiation Oncology
Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.
Pittsburgh :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Pittsburgh : Hillman Cancer Center
Pilot Study for Locally Advanced Head and Neck Cancer
Pittsburgh : St. Clair Hospital
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Pittsburgh : Allegheny General Hospital
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Pittsburgh :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Pittsburgh, : University of Pittsburgh
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Rockledge : Fox Chase Cancer Center
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
Sayre : Call for Information (Investigational Site 0008) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Sayre : Call for Information (Investigational Site 0346)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Scranton : Scranton Hematology Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
State College : Mount Nittany Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
West Chester : The Chester County Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
West Reading : Call for Information (Investigational Site 0016)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
West Reading : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
West Reading : Reading Hospital and Medical Center
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Willow Grove : Call for Information (Investigational Site 0248)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
York : Cancer Care Associates of York
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Rhode Island
East Providence : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Providence : Investigational Site Number 1142
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Providence : Bayside Endoscopy Center
Third Eye Retroscope Randomized Clinical Evaluation
South Carolina
Charleston : Call for Information (Investigational Site 0048) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Charleston : Charleston Hematology Oncology Associates, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Charleston : Call for Information (Investigational Site 0316)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Charleston : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Charleston : Medical University of South Carolina
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
View More »
Charleston : Charleston Cancer Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Charleston : Medical University of South Carolina (MUSC)
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Charleston : Investigational Site Number 840009
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Charleston : Medical University of South Carolina
Tracking Renal Tumors After Cryoablation Evaluation
Columbia : South Carolina Oncology Associates, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Greenville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
Greenville : Research Site
A Study of AMG 820 in Subjects With Advanced Solid Tumors
Greenville : Pfizer Investigational Site
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
Greenville :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Greenville : Cancer Centers of the Carolinas CCC Faris
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Greenville :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Mrytle Beach :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Myrtle Beach : Carolina Urologic Research Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Myrtle Beach : Carolina Urologic Research Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Myrtle Beach : Carolina Urologic Research Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Myrtle Beach :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Spartanburg : Urology Center of Spartanburg
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sumter : Santee Hematology/Oncology
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
West Columbia : Lexington Oncology Associates, LLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
South Dakota
Rapid City : Call for Information (Investigational Site 0241)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Sioux Falls : Avera Cancer Institute, Avera Medical Group Oncology and Hematology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sioux Falls : Call for Information (Investigational Site 0151)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Watertown : Call for Information (Investigational Site 0225)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Watertown :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Tennessee
Bartlett : Family Cancer Center Foundation, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Cookeville : Cookeville Regional Medical Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Germantown : The Jones Clinic, PC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Germantown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Germantown : Call for Information (Investigational Site 0405)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
View More »
Germantown : Gastro One
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Knoxville : 1200.75.10049 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Memphis : The West Clinic West Clin
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Memphis : Family Cancer Center Foundation, Inc.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Memphis : The West Clinic
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Memphis : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Memphis : Call for Information (Investigational Site 0005)
A Study of Ridaforolimus in Pediatric Patients With Advanced Solid Tumors (MK-8669-056)
Memphis : GSK Investigational Site
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Memphis : St. Jude Children's Research Hospital
A Trial of RAD001 and Avastin in Children With Recurrent Solid Tumors
Memphis : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Memphis : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Memphis : Mroz Baier Breast Care Clinic
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Memphis : Call for Information (Investigational Site 0005)
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
Mountain Home : James H. Quillen Veterans Affairs Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Nashville : Sarah Cannon Research Institute SC
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Nashville : Sara Cannon Research Institute
A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Nashville : Pfizer Investigational Site
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Patients With Advanced Cancer
Nashville : Sarah Cannon Research - Drug Development Unit
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Nashville :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Nashville : Sarah Cannon Research Institute
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies
Nashville : Urology Associates, PC
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Nashville : Call for Information (Investigational Site 0053) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Nashville : Tennessee Oncology, Centennial Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Nashville : Urology Associates, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Nashville : Vanderbilt University Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Nashville : Pfizer Investigational Site
A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors
Nashville :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Nashville :
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
Nashville : GSK Investigational Site
A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Nashville : Sarah Cannon Research Institute
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Nashville :
A Study of GDC-0575 Alone And in Combination With Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
Nashville : ImClone Investigational Site
A Study of IMC-TR1 in Patients With Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute (SCRI)
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
Nashville : Investigational Site Number 840002
A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Nashville : Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3023414 in Participants With Advanced Cancer
Nashville : Urology Associates, PC
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Nashville : Sarah Cannon Research Institute
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Nashville :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
Nashville : Call for Information (Investigational Site 0016) Updated
A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025 AM3)
Nashville : Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
Nashville :
A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Nashville : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Nashville : Investigational Site Number 840001
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Nashville :
Dose Escalation Study of INK128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Nashville :
Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Nashville : The Sarah Cannon Research Institute
Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
Nashville : Tennessee Oncology, PLLC
Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors
Nashville :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Nashville : Call for Information (Investigational Site 0232)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Nashville : Investigational Site Number 840007
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Nashville : Vanderbilt University
Phase 1 Safety Study of X-396, an Oral ALK Inhibitor, in Patients With Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute
Phase 1 Safety Study of X-396, an Oral ALK Inhibitor, in Patients With Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute
Phase 1 Study of ONX 0912 Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors
Nashville : Tennessee Oncology, PLLC
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
Nashville : Nashville Breast Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Nashville : Tennessee Oncology
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Nashville : Esanex Investigational Site
Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies
Nashville : Sarah Cannon Research Institute
Safety and PK Study of RRx-001 in Cancer Subjects
Nashville : Vanderbilt-Ingram Cancer Center
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Nashville : Vanderbilt-Ingram Medical Center
Safety Study of PLX108-01 in Patients With Solid Tumors
Nashville : Sarah Cannon Research Institute
Safety Study of X-82 in Patients With Advanced Solid Tumors
Nashville : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Nashville :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Nashville : Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Nashville : Sarah Cannon Research Institute
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Nashville : Tennessee Oncology
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Nashville : Sarah Cannon Research Institute
Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Nashville : Vanderbilt University
Tracking Renal Tumors After Cryoablation Evaluation
Nashville : Monroe Carell Jr. Children's Hospital at Vanderbilt
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Nashville : Sarah Cannon Research Institute
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Texas
Abilene : Hendrick Medical Center / Hendrick Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Abilene : Texas Oncology-Abilene
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Amarillo : Call for Information (Investigational Site 0295)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Amarillo : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Amarillo :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
View More »
Arlington : Texas Oncology - Arlington North
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Arlington : Texas Oncology - Arlington South
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Texas Oncology - Austin Midtown
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Texas Oncology - Austin North
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Texas Oncolocy - South Austin
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Austin : Call for Information (Investigational Site 0404)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Beaumont : Texas Oncology - Beaumont, Mamie McFaddin Ward Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Bedford : Texas Oncology, P.A.
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Bedford : Call for Information (Investigational Site 9093) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Bedford :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Cedar Park : Texas Oncology - Cedar Park
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Corpus Christi : Cancer Specialists of South Texas, PA
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Corpus Christi : Call for Information (Investigational Site 0406)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Corpus Christi : Call for Information (Investigational Site 0372)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Corpus Christi : 1200.75.10037 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Dallas : Texas Oncology - Baylor Sammons Cancer Center
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Dallas : Texas Oncology, P.A.
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Dallas : Urology Clinics of North Texas
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Dallas : Call for Information (Investigational Site 0002) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Dallas : Call for Information (Investigational Site 0011) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Dallas : Texas Oncology - Baylor Charles A. Sammons Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dallas : Texas Oncology - Dallas Presbyterian Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dallas : Urology Clinics of North Texas, PLLC
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Dallas : Mary Crowley Cancer Research Centers - Medical City
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Dallas : Investigational Site Number 840003
A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma
Dallas : Call for Information (Investigational Site 0366)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Dallas : UT Southwestern Medical Center - Simmons Cancer Center
Clinical Trial of ARQ 761 in Advanced Solid Tumors
Dallas : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Dallas : Investigational Site Number 840003
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Dallas : Mary Crowley Cancer Research Centers
Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Dallas : Mary Crowley Cancer Center
Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
Dallas : Mary Crowley Cancer Research Center
Phase 1 Study of ONT-10 in Patients With Solid Tumors
Dallas : Mary Crowley Cancer Research Centers
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Dallas : Mary Crowley Cancer Research Centers
Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Dallas : Mary Crowley Cancer Research Centers
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Dallas : Texas Health
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Dallas : Mary Crowley Medical Research Center
Safety Study of Infusion of SGT-53 to Treat Solid Tumors
Dallas : Texas Oncology, PA (North)
Safety Study of PLX108-01 in Patients With Solid Tumors
Dallas :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Dallas : Texas Oncology - Baylor Charles A. Sammons Cancer Center
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Denton : Texas Oncology - Denton South
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Edinburg : McAllen Oncology
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
El Paso : Texas Oncology - El Paso Cancer Treatment Center Grandview
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
El Paso : Texas Oncology - El Paso Cancer Treatment Center Gateway
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : Texas Oncology - Southwest Fort Worth
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : Texas Oncology - Fort Worth 12th Avenue
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Fort Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Advanced Cancer
Galveston : Call for Information (Investigational Site 0027)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Grapevine : Texas Oncology
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Houston : UT MD Anderson Cancer Center
5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Phase 1 Study in Patients With Advanced Cancer
Houston :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Houston : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Houston : University of Texas, M.D. Anderson Cancer Center
A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors
Houston : Investigational Site Number 840002
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
Houston : Call for Information (Investigational Site 0005) Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Head and Neck Cancer
Houston : Research Site
A Study of AMG 337 in Subjects With Advanced Solid Tumors
Houston : MD Anderson Cancer Center
A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours
Houston : MD Anderson Cancer Center/University of Texas MD Anderson 2
A Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Houston : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Houston : The University of Texas M. D. Anderson Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Houston :
A Study of RO5185426 (Vemurafenib) in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Houston :
A Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Cancers
Houston : Call for Information (Investigational Site 0255)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Houston : Call for Information (Investigational Site 0355)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Houston : MD Anderson Cancer Center/University of Texas Dept of MD Anderson (8)
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Houston : Site Reference ID/Investigator# 26524
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors
Houston : 1200.89.10004 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Houston :
An Extension Study of RO5045337 in Patients Participating in Previous Cancer Studies
Houston : UT MD Anderson Cancer Center
Bendamustine and Bevacizumab for Advanced Cancers
Houston : The University of Texas MD Anderson Cancer Center
Clinical Study of WT2725 in Patients With Advanced Solid Malignancies
Houston : UT MD Anderson Cancer Center
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Houston : The University of Texas MD Anderson Cancer Center
Combination Trial MSC1936369B With Temsirolimus
Houston : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Houston : U T M D Anderson Cancer Center
Dose-escalation Study of Oral CX-4945
Houston : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Houston : M.D. Anderson Cancer Center
First-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor EMD 1214063 in Subjects With Advanced Solid Tumors
Houston : UT MD Anderson Cancer Center
Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Houston : Research Site
Panitumumab Pediatric Study
Houston : UT MD Anderson Cancer Center
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Houston : UT MD Anderson Cancer Center
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Houston : UT MD Anderson Cancer Center
Phase 1 Study of BAX69 in Solid Tumors
Houston :
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Houston : MD Anderson Cancer Center
Phase I, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
Houston : UT MD Anderson Cancer Center
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
Houston :
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With MEK (Mitogen-activated Protein Kinase) Inhibitor BAY86-9766 in Patients With Advanced Cancer
Houston : UT MD Anderson Cancer Center
Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)
Houston : Investigational Site Number 840002
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Houston : UT MD Anderson Cancer Center
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Houston : The Methodist Hospital
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Houston : University of Texas M.D. Anderson Cancer Center
Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases
Houston : University of Texas MD Anderson Cancer Center
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Houston : Call for Information (Investigational Site 0002) Updated
Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049 AM1)
Houston : MD Anderson Cancer Center
Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer
Houston : Research Site
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders
Houston : Research Site
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Houston : MD Anderson Cancer Insititute
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
Houston :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Houston : MD Anderson Cancer Center
Study of KB004 in Subjects With Hematologic Malignancies
Houston : Call for Information (Investigational Site 0003)
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650 AM1)
Houston : UT MD Anderson Cancer Center
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Houston : Investigational Site Number 840001
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Houston : University of Texas - MD Anderson Cancer Center
Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor
Killeen : Call for Information (Investigational Site 0314)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Kyle : Texas Oncology - Kyle
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Laredo :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Laredo :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Lewisville : Texas Oncology - Lewisville
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Lubbock : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Lubbock : Call for Information (Investigational Site 0272)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Lubbock : 1200.75.10014 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
McAllen : Urology Associates of South Texas
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
New Braunfels : Call for Information (Investigational Site 0441)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Round Rock : Texas Oncology - Round Rock
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Round Rock : Texas Oncology - Seton-Williamson
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Round Rock : Call for Information (Investigational Site 0245)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Round Rock :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
San Antonio : Investigational Site Number 840006
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
San Antonio : AVEO Clinical Site
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
San Antonio : START
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Phase 1 Study of LY2835219 In Subjects With Advanced Cancer
San Antonio : University of Texas Health Science Center at San Antonio
A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen
San Antonio : Urology San Antonio Research
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
San Antonio : Research Site
A Study of AMG 820 in Subjects With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics, LLC
A Study of DS-2248, in Subjects With Advanced Solid Tumors
San Antonio : ImClone Investigational Site
A Study of IMC-TR1 in Patients With Advanced Solid Tumors
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 in Patients With Advanced Cancer
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
San Antonio : Urology San Antonio Research, PA
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC
A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
San Antonio : Call for Information (Investigational Site 0001) Updated
A Study of MK-8109 (Vintafolide) Given With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)
San Antonio :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
San Antonio : Call for Information (Investigational Site 0300)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
San Antonio : Call for Information (Investigational Site 0317)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
San Antonio : Methodist Hospital - Texas Transplant Institute
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
San Antonio : The University of Texas Health Science Center-CTRC
An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
San Antonio : InVisions Consultants, LLC- c/o Institute for Women's Health
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio : InVisions Consultants, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio :
BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
San Antonio : Investigational Site Number 840001
First in Man Study of SAR566658 Administered Every 3 Weeks in Patients With DS6-positive and Refractory Solid Tumors
San Antonio : CTRC at the University of Texas Health Science Center Updated
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors
San Antonio : 1200.43.00109 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
San Antonio : 1200.131.00184 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
San Antonio : Investigational Site Number 840005
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
San Antonio :
Phase 1 Dose Escalation Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors
San Antonio :
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics
Phase 1 Study of ONX 0912 Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics (START)
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
San Antonio : Cancer Care Centers of South Texas
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
San Antonio : START Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
San Antonio : Investigational Site Number 840006
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
San Antonio : South Texas Accelerated Research Therapeutics
Safety Study of AB0024 in Patients With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
San Antonio :
Sorafenib Long Term Extension Program (STEP)
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Study in Head and Neck Cancer
San Antonio : South Texas Accelerated Research Therapeutics, LLC
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
San Antonio :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
San Antonio : The START Center
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
San Antonio : START- South Texas Accelerated Research Therapeutics, LLC
Study of PM060184 in Patients With Advanced Solid Tumors
San Antonio : South Texas Accelerated Research Therapeutics (START)
Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
San Marcos : Texas Oncology - San Marcos
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sherman : Texas Oncology - Sherman
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Sugar Land : Texas Oncology - Sugar Land
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Temple : Scott and White Memorial Hospital
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Temple : Call for Information (Investigational Site 0034)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Temple : Call for Information (Investigational Site 0343)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Tyler : Texas Oncology - Tyler
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
Tyler : Tyler Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Tyler : Blood and Cancer Center of East Texas
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Tyler : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Tyler : Digestive Health Specialists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Webster : Texas Oncology - Deke Slayton Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Utah
Murray :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Ogden : Call for Information (Investigational Site 0239)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Pleasant Grove :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Salt Lake City : University of Utah Huntsman Cancer Institute
A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Salt Lake City : University of Utah / Huntsman Cancer Institute Huntsman (3)
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
View More »
Salt Lake City : Huntsman Cancer Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Salt Lake City : Huntsman Cancer Center, University of Utah
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Salt Lake City : ImClone Investigational Site
A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
Salt Lake City :
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Salt Lake City : Call for Information (Investigational Site 0313)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Salt Lake City : Wasatch Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Salt Lake City : GSK Investigational Site
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Salt Lake City : Investigational Site Number 840002
Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
Salt Lake City : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Salt lake City : 1200.75.10043 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Salt Lake City : University of Utah / Huntsman Cancer Institute Huntman 2
MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations
Salt Lake City : Call for Information (Investigational Site 0235)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Salt Lake City : University of Utah
Phase 1 Pharmacokinetics Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Salt Lake City : GSK Investigational Site
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Salt Lake City :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Salt Lake City : University of Utah / Huntsman Cancer Institute
Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function
Sandy :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Vermont
Burlington : 1200.75.10011 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Virginia
Alexandria : Hematology/Oncology Associates
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Charlottesville : University of Virginia Health System
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Charlottesville : University of Virginia Health System
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Charlottesville : University of Virginia
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Fairfax :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
View More »
Lynchburg : Lynchburg Hematology Oncology Clinic
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Newport News :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Norfolk : Urology of Virginia / SMG
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Norfolk : Urology of Virginia, Sentara Medical Group
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Norfolk : Digestive and Liver Disease Specialists
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Norfolk : Virginia Oncology Associates
Safety Study of PLX108-01 in Patients With Solid Tumors
Norfolk :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Portsmouth : Portsmouth Naval Medical Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Richmond : McGuire Veterans Affairs Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Richmond :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Richmond : Call for Information (Investigational Site 0245)
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM2)
Roanoke : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Washington
Burien : Seattle Urology Research Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Lacey :
Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Poulsbo : Harrison Poulsbo Hematology & Oncology
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Renton :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Seattle : Seattle Cancer Care Alliance / University of Washington
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
View More »
Seattle : Research Site
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
Seattle : Seattle Cancer Care Alliance
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Seattle : Virginia Mason Medical Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Seattle : Seattle Cancer Care Alliance
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Seattle : University of Washington
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Seattle : Virginia Mason Medical Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Seattle : Site Reference ID/Investigator# 23285
A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors
Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Seattle : Pfizer Investigational Site
A Study Of PF-04449913 In Select Hematologic Malignancies
Seattle : ImClone Investigational Site
A Study of Ramucirumab and Paclitaxel in Patients With Solid Tumors
Seattle :
A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Seattle : Call for Information (Investigational Site 0347)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Seattle : Swedish Cancer Institute
Breath Test for Early Detection of Lung Cancer
Seattle : GSK Investigational Site
Dose-Escalation Study of GSK2126458
Seattle : Fred Hutchinson Cancer Research Center
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Seattle : Seattle Cancer Care Alliance
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
Seattle :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Seattle : Swedish Medical Center Dept.ofSwedishMedicalCtr.(2)
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Seattle : Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Spokane : Medical Oncology Associates, PS
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Spokane :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Spokane : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Spokane : Rockwood Clinic
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Spokane : Evergreen Hematology & Oncology
Safety Study of PLX108-01 in Patients With Solid Tumors
Spokane :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Tacoma :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Tacoma : Call for Information (Investigational Site 0029)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Tacoma : Comprehensive Clinical Development NW, Inc.
A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
Tacoma : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Tacoma : Multicare Regional Cancer Center
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
Vancouver : Northwest Cancer Specialists, P.C.
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Wenatchee : Wenatchee Valley Medical Center
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Wenatchee : Call for Information (Investigational Site 0428)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Wenatchee : GSK Investigational Site
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Wenatchee : 1200.131.00183 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
West Virginia
Beckley : Raleigh Regional Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Morgantown : West Virginia University Mary Baab Randolph Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Morgantown : Call for Information (Investigational Site 0270)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Morgantown : WVU Mary Babb Randolph Cancer Center
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Morgantown : 1200.75.10045 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Wheeling : The Schiffler Cancer Center
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Wisconsin
Brookfield : Wheaton Franciscan Healthcare - Elmbrook Memorial Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Franklin : Wheaton Franciscan Healthcare - Reiman Cancer Center
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Green Bay : Call for Information (Investigational Site 0122)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Green Bay : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
La Crosse : Call for Information (Investigational Site 0236)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
View More »
La Crosse : Gundersen Lutheran
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Madison :
A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies
Madison : Site Reference ID/Investigator# 6653
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Madison : Updated
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Madison : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Madison : University of Wisconsin Comprehensive Cancer Center
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Madison : University of Wisconsin Madison, Carbone Cancer Center
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Madison : Call for Information (Investigational Site 0311)
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Madison : University of Wisconsin Comprehensive Cancer Center
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Madison : Kenneth DeSantes., MD
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors
Madison : University of Wisconsin Carbone Cancer Center
Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Madison : University of Wisconsin Univ Wisc
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Madison :
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Milwaukee : Medical College of Wisconsin
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Milwaukee : Wheaton Franciscan Healthcare - St. Francis Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Milwaukee : Wheaton Franciscan Healthcare - St. Joseph's Hospital
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Milwaukee : Medical College of Wisconsin
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Milwaukee : Medical College of Wisconsin, Inc.
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Milwaukee :
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Milwaukee : Aurora Cancer Care
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Milwaukee : Columbia St. Mary's Cancer Center
Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Milwaukee : Children's Hospital of Wisconsin
Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Waukesha : Waukesha Memorial Hospital (ProHealth Care)
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Wauwatosa : Wheaton Franciscan Healthcare -Wauwatosa Cancer Care
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Argentina
Almagro : 1200.43.05404 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Buenos Aires :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Buenos Aires : Merck Sharp & Dohme (Argentina) Inc.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Buenos Aires : 1200.75.54005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Buenos Aires : 1200.131.05455 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
View More »
Capital Federal : 1200.75.54001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ciudad Aut6noma de Buenos Aires : GSK Investigational Site
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Ciudad Autonoma de Buenos Aires : 1200.75.54010 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Ciudad Autonoma de Buenos Aires : 1200.43.05401 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Ciudad Autonoma de Buenos Aires : 1200.131.05451 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Cordoba :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Cordoba : 1200.75.54009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
La Plata :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Mendoza :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Pergamino - Buenos Aires : 1200.75.54008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Quilmes :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Quilmes : 1200.75.54003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Rosario :
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
Rosario : 1200.75.54004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Santa Fe : 1200.43.05402 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Santa Fe : 1200.131.05452 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Vicente Lopez : Htal Vicente Lopez
Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients
Villa Dominico : 1200.43.05403 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Villa Dominico : 1200.131.05453 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Australia
Adelaide : 1200.131.06152 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Adelaide : The Queen Elizabeth Hospital
Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer
Adelaide : Royal Adelaide Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Adelaide SA : RAH Cancer Centre, Royal Adelaide Hospital
Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin
Bendigo : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
View More »
Bentleigh East : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Box Hill : 1200.123.6104 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Bunbury : St. John of God Hospital, Bunbury
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Camperdown : 1200.123.6101 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Chermside : 1200.123.6102 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Clayton : Investigational Site Number 036001
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Coffs Harbour : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Darlinghurst : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Douglas : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
East Bentleigh : 1200.89.61002 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
East Melbourne : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2874455 in Patients With Advanced Cancer
East Melbourne : Pfizer Investigational Site
A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
East Melbourne :
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Fitzroy : 1200.75.61001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Fitzroy : Novartis Investigative Site
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Frankston : Frankston Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Frankston : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Frankston : 1200.75.61007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Garran : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Gosford : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Heidelberg : Site Reference ID/Investigator# 60619
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Heidelberg : 1200.123.6105 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Heidelberg (Melbourne) : Ludwig Institute Tumor Targeting Program, Austin Health
An Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Hobart : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Hobart : 1200.131.06153 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Hobart :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Kingswood : Investigational Site Number 036002
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kogarah : 1200.123.6107 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Kogarah : Investigational Site Number 036004
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Kurralta Park : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Kurralta Park : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Kurralta Park :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Launceston : Launceston Gerenal Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Liverpool : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Malvern : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Melbourne :
A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia
Melbourne : Peter MacCallum Cancen Center
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Melbourne : The Alfred Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Milton :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Nambour : Investigational Site Number 036019
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Nedlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Nedlands : 1200.123.6106 Boehringer Ingelheim Investigational Site
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
Nedlands : Linear Clinical Research Ltd
Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours
North Terrace : Royal Adelaide Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Northmead : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Parkville : Research Site
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Parkville : Novartis Investigative Site
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Parkville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2874455 in Patients With Advanced Cancer
Parkville :
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Parkville : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Parkville : Novartis Investigative Site
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Perth : Sir Charles Gairdner Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Perth : 1200.89.61003 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
Perth : 1200.75.61006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Perth : Royal Perth Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Perth : GSK Investigational Site
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Port Macquarie : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Port Macquarie : 1200.75.61002 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Port Macquarie :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Prahran : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Prahran : The Alfred Hospital
Study of KB004 in Subjects With Hematologic Malignancies
Randwick : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Randwick : Research Site
Phase I Comparative Bioavailability Study
Randwick :
Sorafenib Long Term Extension Program (STEP)
Randwick :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Randwick : Investigational Site Number 036003
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Ringwood East : 1200.75.61004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
South Brisbane : Mater Adult Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
South Brisbane : 1200.89.61001 Boehringer Ingelheim Investigational Site
Afatinib (BIBW2992) in HER2-overexpressing Inflammatory Breast Cancer
South Brisbane : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
South Brisbane : Mater Adult Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Subiaco : St. John of Gog Hospital, Subiaco
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Sydney : The Mater Hospital
Use of Hair to Diagnose Breast Cancer
Turnhout : Research Site
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Tweed Heads : Research Site
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Victoria :
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Wahroonga :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Waratah :
A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
Westmead : Novartis Investigative Site
A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors
WestMead : WestMead Hospital
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Westmead : Novartis Investigative Site
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Wodonga : Border Medical Oncology
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Wodonga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Wodonga : Investigational Site Number 036015
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
Wodonga : Border Medical Oncology
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Woodville South : The Queen Elizabeth Hospital
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Wooloongabba : 1200.131.06151 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Austria
Graz : 1200.75.43003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Graz : 1200.43.04302 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Graz : 1200.131.04352 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Innsbruck : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Leoben : 1200.43.04303 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
View More »
Leoben : 1200.131.04353 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Salzburg : 1200.43.04305 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Salzburg : 1200.131.04355 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Salzburg : Investigational Site Number 040002
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Salzburg :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Steyr : 1200.75.43006 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Vienna : Merck Sharp & Dohme Gmbh
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)
Wien : 1200.75.43001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wien : 1200.75.43004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Wien : 1200.43.04306 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Wien : 1200.43.04301 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Wien : 1200.131.04356 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Wien : 1200.131.04351 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Wien : Investigational Site Number 040001
Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
Wien :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Belarus
Minsk : 1200.75.37502 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Minsk region : 1200.75.37501 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Vitebsk : 1200.75.37503 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Belgium
Antwerp : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Antwerp : AZ Stuivenberg
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Antwerp : ZNA Middelheim Oncologie
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Antwerpen : 1200.75.32004 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Brasschaat : 1200.75.32008 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
View More »
Brussel : University Ziekenhuis
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Brussels : Institut Jules Bordet
A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors
Brussels : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Brussels :
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Brussels : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Brussels :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Brussels : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Bruxelles : Merck Sharp & Dohme B.V. Updated
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064 AM2)
Bruxelles : Merck Sharp & Dohme B.V. Updated
A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025 AM3)
Bruxelles : Institut Jules Bordet
Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors
Bruxelles :
Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
Bruxelles : 1200.75.32001 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Bruxelles : 1200.43.03202 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Bruxelles : 1287.1.3201 Boehringer Ingelheim Investigational Site
Monotherapy Dose Finding With BI 847325 in Solid Tumours
Bruxelles : Investigational Site Number 056002
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Bruxelles : CHU Brugmann
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Hôpital Erasme
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Hôpital Saint Pierre
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Institut Jules Bordet
Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma
Bruxelles - Brussel :
Sorafenib Long Term Extension Program (STEP)
Charleroi : 1200.131.03256 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Charleroi :
Sorafenib Long Term Extension Program (STEP)
Edegem :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Edegem : 1200.75.32005 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Edegem : 1200.43.03203 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Edegem : 1200.131.03251 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Edegem : Investigational Site Number 056001
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Edegem : Investigational Site Number 3219
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Gent : University Hospital Gent
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Gent : 1200.43.03204 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Gent : Investigational Site Number 056001
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Haine-Saint-Paul : 1200.75.32009 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Hasselt : 1200.131.03255 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Ixelles : HIS Ixelles
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Jette : AZ VUB
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Jette : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Kortrijk : 1200.131.03253 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Kortrijk : Investigational Site Number 3212
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Leuven : Novartis Investigative Site
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
Leuven : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Leuven : 1200.43.03201 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Leuven : 1287.1.3202 Boehringer Ingelheim Investigational Site
Monotherapy Dose Finding With BI 847325 in Solid Tumours
Leuven : Research Site
Phase I Comparative Bioavailability Study
Leuven : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Leuven : University Hospitals Leuven
Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma
Leuven : Investigational Site Number 3211
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Liege : CHU de Liege
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Liege : CHR Citadelle
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Liege : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Liège : 1200.75.32003 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Liège : 1200.131.03254 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Liège : 1200.131.03252 Boehringer Ingelheim Investigational Site
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
Liège :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Namur : GSK Investigational Site
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer
Namur : GSK Investigational Site
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Namur : Investigational Site Number 3213
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Oostende : 1200.75.32007 Boehringer Ingelheim Investigational Site
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Roeselare :
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Turnhout : AZ Turnhout Dienst Urologie
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Verviers : Investigational Site Number 056002
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
West Flanders : Burgemeester Vercruysselaan
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Wilrijk :
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Wilrijk :
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
Wilrijk : Novartis Investigative Site
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Wilrijk : Novartis Investigative Site
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Wilrijk : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Wilrijk : Investigational Site Number 3218
Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Yvoir : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Bosnia and Herzegovina
Banja Luka : Synta Pharmaceuticals Investigative Site
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Mostar : Synta Ph
